Non-Hodgkin's Lymphoma and Spondylitis in Type-2 Diabetes Mellitus: A Rare Geriatric Case Report
Abstract
Purpose- Type 2 diabetes mellitus is a metabolic condition characterized by organ failure. In patients with type 2 diabetes, maintaining tight glycaemic control requires timely adjustments and changes in therapy. In children and adolescents, spondylolysis is a common cause of back pain. Spondylitis is more common in men than in women, and it is caused by a congenital defect. T-cell Non-Hodgkin lymphomas are a rare cancer of the lymphatic system. NHL are lymphoid tumours caused by chromosomal translocations, infections, immunodeficiency states, environmental causes, or persistent inflammation.
Methods- A 65 years old male patient admitted to the tertiary care hospital. Past medical history of patient includes he was suffering from lower back pain along with increased blood sugar level since1 month. Past medical history of patient was Type-2 diabetes mellitus since 3years, spondylitis since 6month along with newly detected Non-Hodgkin’s lymphoma. T-cell Non-Hodgkin lymphomas are a rare cancer of the lymphatic system. There are 9 different clinics pathologic peripheral T-cell NHLs recognized by the current WHO/EORTC classification.
Result and Conclusion- Early diagnosis is important for effective and curative therapy management. Early investigations include MRI, Chest X-ray and Ultrasonography. MRI examination of the spine is particularly helpful to diagnose and treatment of this rare disease.
Keywords- Oral Anti-Diabetic Drugs, Non-Hodgkin’s Lymphoma, Spondylitis, Diabetes mellitus, spondylolisthesis
Keywords:
Oral Anti-Diabetic Drugs, Non-Hodgkin’s Lymphoma, Spondylitis, Diabetes mellitus, spondylolisthesisDOI
https://doi.org/10.22270/jddt.v12i3.5339References
Yurube T, Kakutani K, Okamoto K et al. Lumbar spondylolysis: A report of four cases from two generations of a family. Journal of Orthopaedic Surgery. 2017; 25(2):230949901771391. https://doi.org/10.1177/2309499017713917
Park K, Ha J, Kim H et al. Multiple Levels of Lumbar Spondylolysis - A Case Report -. Asian Spine J. 2009; 3(1):35. https://doi.org/10.4184/asj.2009.3.1.35
Middleton K, Fish D. Lumbar spondylosis: clinical presentation and treatment approaches. Curr Rev Musculoskeletal Med. 2009; 2(2):94-104. https://doi.org/10.1007/s12178-009-9051-x
Shin E, Drucker D, Brubaker P. Glucagon-like peptide 2: an update. Curr Opin Endocrinol Diabetes. 2005; 12(1):63-71. https://doi.org/10.1097/01.med.0000150855.40298.db
Levy P. Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes. MedGenMed. 2007; 9(2):12. Published 2007 Apr 16. PMID: 17955068; PMCID: PMC1994837.
Kuritzky L. Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy. MedGenMed. 2006; 8(4):34. Published 2006 Nov 15. PMID: 17415316; PMCID: PMC1868361.
Chaudhari D, Khan S, Saleem A et al. Obstructive Jaundice as an Initial Manifestation of Non-Hodgkin Lymphoma: Treatment Dilemma and High Mortality. Case Rep Med. 2013; 2013:1-5. https://doi.org/10.1155/2013/259642
Rizvi MA, Evens AM, Tallman MS, Nelson BP, Rosen ST. T-cell non-Hodgkin lymphoma. Blood. 2006; 107(4):1255-1264. https://doi.org/10.1182/blood-2005-03-1306
Chun Chao, John H. Page, Type 2 Diabetes Mellitus and Risk of Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis, American Journal of Epidemiology, 2008; 168(1):471-480, https://doi.org/10.1093/aje/kwn160
Park, CH., Min, KB., Min, JY. et al. Strong association of type 2 diabetes with degenerative lumbar spine disorders. Sci Rep 2021; 11:16472. https://doi.org/10.1038/s41598-021-95626-y
Binder AI. Cervical spondylosis and neck pain. BMJ. 2007; 334(7592):527-531. https://doi.org/10.1136/bmj.39127.608299.80
Buyukavci, Raikan. A Case with Ankylosing Spondylitis Who Developed Hodgkin Lymphoma Following Etanercept Therapy. Journal of Arthritis. 2013; 02. https://doi.org/10.4172/2167-7921.1000114
Published
Abstract Display: 469 
PDF Downloads: 575 PDF Downloads: 45 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.